Selected 2006 Strategic Alliances, Joint Venture and Licensing Transactions

Selected 2006 Strategic Alliances, Joint Venture and Licensing Transactions

Publication
  • Airwide Solutions — US and international reseller and sales agreements
  • Alantos Pharmaceuticals — Collaboration with Servier for oral administration treatment for type 2 diabetes
  • Alnylam Pharmaceuticals — Collaboration with Novartis Institutes for BioMedical Research to develop RNAi therapeutics for pandemic flu
  • Applix — International software solution partner agreement
  • AVEO Pharmaceuticals — License from Kirin Brewery of clinical-stage cancer product
  • Avid Technology — Key licensing, distribution and supply agreements for Avid Technology and its Digidesign division
  • Bose — Various licensing and collaboration matters
  • Braintree Laboratories — License to Schering-Plough of MiraLAX® over-the-counter gastrointestinal products
  • Broadcom — Licenses in connection with various acquisitions
  • Brooks Automation — Formation of Japanese joint venture with Yaskawa Electric
  • Cephalon — Licensing advice in connection with settlements of Provigil® generic patent infringement litigation
  • Constant Contact — Various co-promotion and licensing matters
  • Emergent BioSolutions — Supply agreements for a therapeutic anthrax immune globulin product
  • From the Top — Agreements with WGBH, Carnegie Hall and others for production of public television series
  • Idera Pharmaceuticals — Collaboration with Merck to develop vaccines incorporating toll-like receptor agonists
  • IETF — Advice to the leading standards body for the Internet
  • IGA Worldwide — Online game advertising agreement with Electronic Arts
  • Infinity Pharmaceuticals — Alliance with MedImmune for novel small molecule cancer drugs
  • Momenta Pharmaceuticals — Alliance with Sandoz to develop complex generic and follow-on biotechnology drugs
  • Palm — Various patent licenses
  • Panera Bread — Licensing and supply arrangements for Canadian retail expansion
  • PTC Therapeutics — Collaboration with Schering-Plough for the development of hepatitis C virus drugs
  • ReGen Therapeutics — Distribution and marketing of nutraceutical compounds through Metagenics
  • SiCortex — Various development, manufacturing, services and distribution agreements
  • Silicon Integration Initiative — Formation of low-power integrated circuit design flow coalition
  • Starent Networks — International distribution agreements and licensing transactions
  • Sucampo Pharmaceuticals — Licensing advice in connection with corporate reorganization
  • Syntonix Pharmaceuticals — Strategic alliance with Biovitrum for long-acting hemophilia B product
  • Xanthus — Acquisition from Schering AG of rights to clinical-stage cancer compounds
  • Ziopharm — Acquisition from Baxter Healthcare of clinical-stage anti-cancer agent program

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link. (The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.